Myron W. Shulgan insider trades

Open-market stock purchases and sales by Myron W. Shulgan, Director at Drugs Made In America Acquisition II Corp, from SEC Form 4 filings since Jan 29, 2025.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • DMII Drugs Made In America Acquisition II Corp: other filings, last Sep 26, 2025
  • DMAA Drugs Made In America Acquisition Corp: other filings, last Jan 29, 2025

Get free alerts when Myron W. Shulgan files a new trade →